Market News

Taysha Gene Therapies: A Spark in the Market Taysha Gene Therapies: A Spark in the Market



Shares of Taysha Gene Therapies, Inc. TSHA soared in today’s pre-market session following the company’s robust fiscal year 2023 earnings per share results.


For the fiscal year 2023, the company reported losses of 96 cents per share, a notable improvement from losses of $3.78 per share in the previous year. Taysha disclosed holding $143.9 million in cash and cash equivalents as of December 31, 2023.


Apart from the financials, the company also updated investors on its clinical progress, including the successful dosing completion in the first cohort of its REVEAL Phase 1/2 adolescent and adult trial, along with the expansion and site activation in the U.S. for an ongoing trial previously in Canada.


Taysha Gene Therapies witnessed a substantial 27.1% surge to $2.86 in pre-market trading.


Here are some other stocks making moves in pre-market trading.


Movers and Shakers


  • ETAO International Co., Ltd. ETAO saw a significant 200.4% surge to $0.4296 in early trading after announcing a reverse stock split.
  • Oblong, Inc. OBLG rose by 48.2% to $0.20 in pre-market activity subsequent to its fourth-quarter financial results release and business update.
  • BYND Cannasoft Enterprises Inc. BCAN climbed 44% to $0.0288 in early trading, rebounding from a 15% decline the prior day. The company was the subject of a $7.0 million underwritten public offering, with Aegis Capital as the Sole bookrunner.
  • Mangoceuticals, Inc. MGRX observed a 40.5% upswing to $0.2698 in pre-market trading after a 4% increase on Tuesday.
  • EZFill Holdings Inc. EZFL recorded an 18% gain to $1.90 in pre-market trading post a 9% drop a day earlier.
  • SCWorx Corp. WORX jumped by 16.9% to $3.32 in pre-market trading following a staggering 54% surge on Tuesday.
  • BitFuFu Inc. FUFU posted an 11.7% rise to $6.03 in pre-market trading after a 32% climb the previous day.
  • Canopy Growth Corporation CGC surged by 14.4% to $4.38 in pre-market trading, buoyed by Vice President Kamala Harris’s recent call for the DEA to reconsider marijuana classification.
  • Getty Images Holdings, Inc. GETY escalated by 14% to $5.36 in pre-market trading led by a positive fourth-quarter revenue report and optimistic FY24 revenue guidance.
See also  Insight Into Goldman Sachs: Is It Time to Buy? Insight Into Goldman Sachs: Is It Time to Buy?


Stocks Heading South


  • Ontrak, Inc. OTRK dipped by 20.5% to $0.35 in pre-market trading following a hefty 131% surge on Tuesday.
  • Momentus Inc. MNTS saw a 19.1% decline to $0.4803 in pre-market trading after a 17% rise the day before, catalyzed by a US patent grant.
  • Aquestive Therapeutics, Inc. AQST fell by 14.8% to $4.55 in early trading following the pricing of a $75 million underwritten public offering of 16,666,667 common shares at $4.50 per share.
  • Verb Technology Company, Inc. VERB dropped by 14.2% to $0.3309 in pre-market trading after a 7% rise on Tuesday. The company recently integrated Facebook and Instagram social shopping technology on Market.live and expanded its retail brand portfolio.
  • Harrow, Inc. HROW tumbled by 14.6% to $9.09 in pre-market trading following below-par fourth-quarter financial results.


 


Now Read This: Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday



We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.